45
Dvant Pharma raises $3.09M in first Regulation D offering from Michigan biotech
Company raise · Raising · SUPERIOR TOWNSHIP, MI · Form D filed 2026-10-13
Dvant Pharma, a Delaware corporation based in Superior Township, Michigan, is raising $3.09M under Regulation D exemption 6(b). The company has sold $1.23M to 9 investors so far, with $1.86M remaining in the offering.
Note: First raise on EDGAR; no year of incorporation provided; no placement agent listed despite active fundraising.
First raise on EDGARother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Andrew Joseph Kocab | Executive Officer, Director |
| Mukesh Nyati | Executive Officer, Director |
| Vincent Alessi | Director |
| Jim Adox | Director |
| Frank Perabo | Director |
Signed by Andrew Joseph Kocab, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.